Literature DB >> 16459490

Piracetam--an old drug with novel properties?

Katarzyna Winnicka1, Marian Tomasiak, Anna Bielawska.   

Abstract

Piracetam (2-oxo-1-pyrrolidine-acetamide), the most common of the nootropic drugs, is a cyclic derivative of gamma-aminobutyric acid. The treatment with piracetam improves learning, memory, brain metabolism, and capacity. Piracetam has been shown to alter the physical properties of the plasma membrane by increasing its fluidity and by protecting the cell against hypoxia. It increases red cell deformability and normalizes aggregation of hyperactive platelets. Piracetam is an agent with antithrombotic, neuroprotective and rheological properties. The interaction of this molecule with the membrane phospholipids restores membrane fluidity and could explain the efficacy of piracetam in various disorders ranging from dementia and vertigo to myoclonus and stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16459490

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  16 in total

1.  Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.

Authors:  Happy Sawires; Osama Botrous
Journal:  Eur J Pediatr       Date:  2012-07       Impact factor: 3.183

2.  Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.

Authors:  Pankaj Paliwal; Debabrata Dash; Sairam Krishnamurthy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

3.  Effects of Smart Drugs on Cholinergic System and Non-Neuronal Acetylcholine in the Mouse Hippocampus: Histopathological Approach.

Authors:  Ryusei Satoh; Kiyoharu Kawakami; Kazuhiko Nakadate
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

4.  A drug utilization study of cognition enhancers in dementia in a tertiary care hospital in mumbai.

Authors:  Karan Thakkar; Shaurya Suman; Gauri Billa
Journal:  J Clin Diagn Res       Date:  2014-05-15

5.  Protective effect of Bajijiasu against β-amyloid-induced neurotoxicity in PC12 cells.

Authors:  Di-Ling Chen; Peng Zhang; Li Lin; Ou Shuai; He-Ming Zhang; Song-Hao Liu; Jin-Yu Wang
Journal:  Cell Mol Neurobiol       Date:  2013-06-29       Impact factor: 5.046

6.  Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.

Authors:  Dinesh Kumar Verma; Sonam Gupta; Joyshree Biswas; Neeraj Joshi; K Sivarama Raju; Mu Wahajuddin; Sarika Singh
Journal:  Neurotox Res       Date:  2018-03-12       Impact factor: 3.911

7.  Evaluation of Nootropic Activity of Limonia acidissima Against Scopolamine-induced Amnesia in Rats.

Authors:  Kailas K Mali; Guruprasad V Sutar; Remeth J Dias; Omkar A Devade
Journal:  Turk J Pharm Sci       Date:  2021-02-25

8.  The developing utility of zebrafish models for cognitive enhancers research.

Authors:  Adam Michael Stewart; Allan V Kalueff
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

9.  Augmented memory: a survey of the approaches to remembering more.

Authors:  Christopher R Madan
Journal:  Front Syst Neurosci       Date:  2014-03-03

10.  Effects of piracetam on pediatric breath holding spells: a randomized double blind controlled trial.

Authors:  Ali Abbaskhanian; Sara Ehteshami; Sadegh Sajjadi; Mohammad Sadegh Rezai
Journal:  Iran J Child Neurol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.